All Posts
DES Pharma at DCAT Week 2026
Engineering Confidence in CMC Development—Let’s Connect in New York City DES Pharma (Dynamic Engineering Solutions)
February 11, 2026
Engineering Confidence in CMC Development—Let’s Connect in New York City DES Pharma (Dynamic Engineering Solutions)
Developing a therapeutic from lab to commercial launch requires much more than scientific innovation. it
Pharmaceutical quality assurance continues its evolution toward data-driven decision-making, process analytical technology, and risk-based validation
Executive Summary: Defining the New Bio Pharma Supply Chain Strategy The pharmaceutical supply chain in
In many industries, a manufacturing defect means a returned product and a frustrated customer. In
If the pharmaceutical landscape of 2025 was defined by resilience, 2026 is defined
Intro to Pharma Consulting: The Guide Behind the Science When most people think of the
Introduction Some believe that the Chemistry, Manufacturing, and Controls (CMC) section of an IND is
Introduction Drug product in-use studies represent critical yet underestimated components of drug product quality, particularly
Introduction The pharmaceutical supply chain landscape in 2026 continues to evolve at an unprecedented pace.
Start building reliable, high-quality drug development programs today.